Home » Stocks » ShockWave Medical

ShockWave Medical, Inc. (SWAV)

Stock Price: $47.46 USD 0.58 (1.24%)
Updated Jul 2, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 1.60B
Revenue (ttm) 50.86M
Net Income (ttm) -57.09M
Shares Out 33.82M
EPS (ttm) -1.94
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 2, 2020
Last Price $47.46
Previous Close $46.88
Change ($) 0.58
Change (%) 1.24%
Day's Open 47.63
Day's Range 46.49 - 47.90
Day's Volume 243,288
52-Week Range 22.01 - 56.00

More Stats

Market Cap 1.60B
Enterprise Value 1.46B
Earnings Date (est) Aug 10, 2020
Ex-Dividend Date n/a
Shares Outstanding 33.82M
Float 25.65M
EPS (basic) -1.86
EPS (diluted) -1.94
FCF / Share -2.08
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 3.85M
Short Ratio 11.11
Short % of Float 24.08%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 31.53
PB Ratio 9.04
Revenue 50.86M
Operating Income -58.66M
Net Income -57.09M
Free Cash Flow -65.93M
Net Cash 146.19M
Net Cash / Share 4.33
Gross Margin 50.67%
Operating Margin -115.35%
Profit Margin -112.30%
FCF Margin -129.65%
ROA -19.38%
ROE -37.19%
ROIC -56.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (6)

Buy 4
Overweight 0
Hold 2
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(5.35% upside)
Current: 47.46
Target: 50.00
*Average 12-month price target from 5 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth250.05%613.38%-
Gross Profit25.775.01-1.12
Operating Income-51.84-41.20-30.87
Net Income-51.11-41.10-30.62
Shares Outstanding23.901.761.55
Earnings Per Share-2.14-23.39-19.71
Operating Cash Flow-48.11-41.47-30.35
Capital Expenditures-3.82-1.98-0.43
Free Cash Flow-51.92-43.45-30.77
Cash & Equivalents19539.6453.73
Total Debt21.9415.05-
Net Cash / Debt17324.5953.73
Book Value193-123-83.29
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name ShockWave Medical, Inc.
Country United States
Employees 284
CEO Douglas Evan Godshall

Stock Information

Ticker Symbol SWAV
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: SWAV


ShockWave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee peripheral artery disease. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company operates in the United States, Germany, rest of Europe, and internationally. ShockWave Medical, Inc. was incorporated in 2009 and is headquartered in Santa Clara, California.